Recovery of kidney function by rituximab-based therapy in a patient with Waldenström's macroglobulinemia-related nephropathy presenting cast nephropathy and interstitial lymphocytic infiltration

Internal Medicine

Volumn 51, Issue 13, 2012, Pages 1725-1730

  Miwa, Masashi ^a   Sakao, Yukitoshi ^a   Ishigaki, Sayaka ^a   Ono, Masafumi ^a   Fujikura, Tomoyuki ^a   Yasuda, Hideo ^a   Suzuki, Hiroyuki ^a   Kato, Akihiko ^a   Nagata, Yasuyuki ^a   Shigeno, Kazuyuki ^a   Nakamura, Satoki ^a   Ohnishi, Kazunori ^a   Fujigaki, Yoshihide ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cast nephropathy; Hemodialysis; Lymphoplasmacytic lymphoma; Rituximab; Waldenstr m's macroglobulinemia

Indexed keywords

BENCE JONES PROTEIN; CD20 ANTIGEN; CD38 ANTIGEN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN M; MELPHALAN; PREDNISOLONE; RITUXIMAB; SYNDECAN 1; VINCRISTINE;

ADULT; ARTICLE; BONE MARROW EXAMINATION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; DRUG DOSE REDUCTION; ELECTRON MICROSCOPY; HEMODIALYSIS; HEPATOSPLENOMEGALY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FUNCTION; LYMPHADENOPATHY; LYMPHOCYTIC INFILTRATION; MALE; MULTIPLE CYCLE TREATMENT; MULTIPLE MYELOMA; SCLEROSIS; THROMBUS; URINARY CAST; WALDENSTROEM MACROGLOBULINEMIA;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CREATININE; CYCLOPHOSPHAMIDE; HUMANS; KIDNEY DISEASES; LYMPHOCYTES; MALE; MIDDLE AGED; PREDNISOLONE; RENAL DIALYSIS; VINCRISTINE; WALDENSTROM MACROGLOBULINEMIA;

EID: 84863522248     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.51.7207     Document Type: Article

References (16)

1. Harris NL, Jaffe ES, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 17: 3835-3849, 1999.
2. Dimopoulos MA, Kyle RA, Anagnostopoulos A, Treon SP. Diagnosis and management of Waldenström's macroglobulinemia. J Clin Oncol 23: 1564-1577, 2005.
3. Vitolo U, Ferreri AJM, Montoto S. Lymphoplasmacytic lymphoma-Waldenström's macroglobulinemia. Critical Reviews in Oncology/Hematology 67: 172-185, 2008.
4. Argani I, Kipkie GF. Macroglobulinemic nephropathy. Acute renal failure in macroglobulinemia of Waldenström. Am J Med 36: 151-157, 1964.
5. Morel-Maroger L, Basch A, Danon F, Verroust P, Richet G. Pathology of the kidney in Waldenström's macroglobulinemia Study of sixteen cases. N Engl J Med 283: 123-129, 1970.
6. Audard V, Georges B, Vanhille P, et al. Renal lesions associated with IgM-secreting monoclonal proliferations: Revisiting the disease spectrum. Clin J Am Soc Nephrol 3: 1339-1349, 2008.
7. Isaac J, Herrera GA. Cast nephropathy in a case of Waldenström's macroglobulinemia. Nephron 91: 512-515, 2002.
8. Pérez N, Garcia-Herrera A, Rosiñol L, et al. Lymphoplasmacytic lymphoma causing light chain cast nephropathy. Nephrol Dial Transplant 27: 450-453, 2012.
9. Dimopoulos MA, Gertz MA, Kastritis E, et al. Update on treatment recommendations from the fourth international workshop on Waldenström's macroglobulinemia. J Clin Oncol 27: 120-126, 2009.
10. Buske C, Hoster E, Dreyling M, et al. The addition of rituximab to front-line therapy with CHOP (R-CHOP) results in a higher response rate and longer time to treatment failure in patients with lymphoplasmacytic lymphoma: results of a randomized trial of the German Low-Grade Lymphoma Study Group (GLSG). Leukemia 23: 153-161, 2009.
11. Herrera GA, Picken MM. Ch 19 Renal Diseases Associated with Plasma Cell Dyscrasias, Amyloidoses, Waldenström Macroglobulinemia and Cryoglobulinemic Nephropathies. In: Heptinstall's Pathology of the Kidney. 6th edition. Jennette JC, Olson JL, Schwartz MM, Silva FG, Eds. Lippincott Williams & Wilkins, Philadelphia, 2007: 853-910.
12. Krajny M, Pruzanski W. Waldenström's macroglobulinemia: Review of 45 cases. Can Med Assoc J 114: 899-900, 1976.
13. Merlini G, Pozzi C. Mechanisms of renal damage in plasma cell dyscrasias: an overview. Contrib Nephrol 153: 66-86, 2007.
14. Kimby E, Treon SP, Anagnostopoulos A, et al. Update on recommendations for assessing response from the Third International Workshop on Waldenström's Macroglobulinemia. Clin Lymphoma Myeloma 6: 380-383, 2006.
15. Izzedine H, Bourry E, Amrouche L, et al. Immunoglobulin M 'Flare' after rituximab-associated acute tubular necrosis in Waldenström's macroglobulinemia. Int J Hematol 89: 218-222, 2009.
16. Shaikh A, Habermann TM, Fidler ME, Kumar S, Leung N. Acute renal failure secondary to severe type I cryoglobulinemia following rituximab therapy for Waldenström's macroglobulinemia. Clin Exp Nephrol 12: 292-295, 2008.